Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::
:::

研究計畫

111年度院外研究計畫

計畫名稱

計畫編號

主持人

執行期間

Accountability and Outcome Measurement of Diabetes Health Promotion Organizations in Taiwan

 

胡啟民

107/09-111/12

Taiwan Diabetes Registry Study

 

胡啟民

104/07-112/12

Efficacy and Safety of LY3298176 Once Weekly versus Insulin Glargine in Patients with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)

I8F-MC-GPGM

胡啟民

107/01-111/12

A 12-month, multicentre, non-interventional, prospective study to describe clinical outcomes after iGlarLixi initiation in patients with Type 2 diabetes mellitus

OBS16039

胡啟民

109/10-111/12

Behavioral intervention and home-based resistance training to increase physical activity and muscle strength in patients with type 2 Diabetes: A randomized clinical trial

MOST 110-2314-B-075-027-MY3

胡啟民

110/08-113/07

Cross-sectional evaluation on the preference of oral agent for the treatment of diabetes (sodium-glucose cotransporter 2 inhibitor, SGLT2I) vs. dipeptidyl peptidase-4 inhibitor, DPP-4I) in patients with T2DM

D1690R00082

胡啟民

110/11-112/12

A 52-week study comparing the efficacy and safety of once weekly IcoSema and once weekly semaglutide, both treatment arms with or without oral anti-diabetic drugs, in participants with type 2 diabetes inadequately controlled with a GLP-1 receptor agonist. COMBINE 2

NN1535-4592

胡啟民

110/04-113/05

A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared with Insulin Degludec in Participants with Type 1 Diabetes Treated with Multiple Daily Injection Therapy

I8H-MC-BDCY

胡啟民

111/09-115/12

邁向2030年智慧醫療大健康跨域計畫(2/2).

NSTC 111-2634-F-A49-014-

陳涵栩(共同主持人)

2022/11/1-2023/10/31;

Role of insulin-like growth factor-1 in the management of acromegaly: Relationship to cardiovascular outcomes and pituitary function.

NSTC 111-2314-B-A49-064-

陳涵栩

2022/8/1-2023/7/31;

邁向2030年智慧醫療大健康跨域計畫(1/2).

NSTC 110-2634-F-A49-005-

陳涵栩(共同主持人)

2021/11/1-2022/10/31

A 26 week double blinded, multiregional trial comparing the effect and safety of once weekly insulin icodec and once daily insulin degludec 100 units/mL, both in combination with non-insulin anti-diabetic drugs, in insulin naïve subjects with type 2 diabetes:

ONWARDS 3

陳涵栩

2021/6/1-2022/12/31

水溶性環氧化物水解酶在肥胖相關代謝異常之病生理功能:造血重編程與腸道菌相之角色.

MOST 109-2320-B-010 -011 -MY3

陳涵栩(共同主持人)

2020/8/1-2023/7/31

激活素 A蛋白在高濃度葡萄糖環境下對人類臍靜脈內皮細胞功能的影響

CI-111-1

郭錦松

2022/1/1-2022/12/31

唾液皮質醇於庫欣氏症診斷及追蹤角色之研究

MOST 111-2314-B-075 -040 -MY2

林亮羽

2022/8/1-2024/7/31

妊娠甲狀腺功能和相關指標與懷孕預後之研究(第二年)

 MOST 110-2314-B-075-007

黃君睿 

 2021/08/1-2022/07/31

甲狀腺疾病患者之碘指標與疾病控制和預後相關性之研究

MOST 111-2314-B-075-071-

黃君睿 

 2022/08/01-2023/07/31

針對葛瑞夫茲氏病及抗甲狀 腺藥物引發無顆粒性白血球 症進行整合性免疫套組基因 及人類白血球表面抗原基因 研究(第二年)

VN111-03

黃君睿

 2022/01/01 -2022/12/31

應用真病人與標準化病人於模擬線上問診之成效探討

MOST 111-2410-H-075 -001 -

黃加璋

2022/08/01  ~   2023/07/31

應用真病人與標準化病人於基礎臨床技能訓練課程之成效探討

MOST 109-2511-H-075 -001 -MY2

黃加璋

2020/08/01~
2022/12/31

慢性單一FXR agonists或合併mosapride治療,對於肝硬化相關免疫機能失調(CAID)時,脾及骨髓免疫細胞異常交互作用及相關血管新生/發炎的異常機轉及治療可行性的探討

MOST 108-2314-B-075 -050 -MY3

林漢傑/黃加璋

2019/08/01~
2022/07/31

 
 

111年度榮總院內研究計畫

計畫名稱

計畫編號

主持人

執行期間

第2型糖尿病人血中生長/分化因子-15與相對肌力縱向關係之研究

V111C-188

胡啟民

111/01-111/12

以小鼠模型探討激活素抑制劑對後肢缺氧性傷害後血管新生之影響

V111C-190

郭錦松

2022/1/1-2022/12/31

糖尿病自主神經病變與其他小血管病變之相關性研究

V111D62-002-MY3-1

林亮羽

2022/1/1-2024/12/31

開發利用感應耦合電漿質譜儀檢測母乳碘之新方法

AACIC020

黃君睿

2021/10-2022/07

母乳碘與尿碘相關性之研究

V111B-001

黃君睿

2022/1/1-2022/1231

應用標準化病人里程碑評估回饋系統於醫事人員客觀結構式臨床技能測驗之成效探討(第二年)

V111EA-011

黃加璋

2022/01/01~

2022/12/31

評估慢性Pioglitazone治療對肝硬化相關腎病變的治療機轉及作用

V111C-038

黃加璋

2022/01/01~

2022/12/31

 
 
 

最後更新:

回到最上